Drug Shortage Report for EPTIFIBATIDE INJECTION

Last updated on 2020-02-13 History
Report ID 1691
Drug Identification Number 02405083
Brand name EPTIFIBATIDE INJECTION
Common or Proper name EPTIFIBATIDE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) EPTIFIBATIDE
Strength(s) 0.75MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 100ML
ATC code B01AC
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-11-01
Estimated end date
Actual end date 2017-03-03
Shortage status Resolved
Updated date 2020-02-13
Company comments Product Discontinued.
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-02-13 French Compare
v3 2020-02-13 English Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare